Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis[1][2][3].
Molecular Weight:
13427.10
Purity:
99.09
CAS Number:
[1386913-72-9]
Target:
Small Interfering RNA (siRNA),Transthyretin (TTR)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted
